Based on our advanced algorithm, we predict that RAPT stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $9.9, while the 1-week outlook suggests a value of $9.2. For the 1-month forecast, we project a price of $9.8. Looking further ahead, our 2026 projection estimates a value of $13.59, with a long-term 2030 forecast reaching $17.14. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RAPT has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
RAPT stock price ended at $9.99 on Wednesday, after losing-1.09%
The RAPT Therapeutics Inc stock price decreased by -1.09% on the last trading day (06 Aug 2025), dropping from 10.01 to 9.99. Throughout the last trading session, the stock experienced a fluctuation of 6.75% , ranging from a day low of $9.5456 to a day high of 10.19. The price has declined in 8 of the last 10 days, resulting in a total change of -28.34% during this period. On the last day, trading volume increase by -16.86K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 21.29K shares were traded, amounting to approximately 210.04K.
RAPT Technical Signals
RAPT(RAPT Therapeutics Inc Corp) has 5 buy signals and 3 sell signals now. The current trend is downtrend starting from 2025-06-17. The total price change during this trend is +28.83%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of RAPT over the last 5 trading days is 357.11K. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
RAPT Therapeutics Inc's overall moving average trend leans more bearish as of Thursday, August 7, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $14.46, and $15.99. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $9.49, and $7.95. A break-down below any of these levels will issue sell signals.
RAPT Short Selling Analysis
The short sale ratio of RAPT Therapeutics Inc(RAPT) as of 05 Aug 2025 is 18.95%, dropping from last trading day. With decreasing price from 10.76 to 10.10. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Buy
Sell
3
Buy
5
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
16.58
Bullish
Awesome Oscillator (5, 34)
AO_5_34 > 0
1.098
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.542
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
1.949
Bullish
Williams %R (14 days)
WILLR_14 < -80
-97.555
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, RAPT Therapeutics Inc (RAPT) is anticipated to change hands in a trading channel between $8.14 and $16.76.
RAPT Therapeutics Inc Stock Forecast 2026
Jan 2026: RAPT Stock Forecast
Potential ROI: 13.67%
In Jan 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $13.28. The price is predicted to fluctuate between a low of $11.73 and a high of $13.63.
Feb 2026: RAPT Stock Forecast
Potential ROI: -6.25%
In Feb 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $10.95. The price is predicted to fluctuate between a low of $10.84 and a high of $11.54.
Mar 2026: RAPT Stock Forecast
Potential ROI: 20.29%
In Mar 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $14.05. The price is predicted to fluctuate between a low of $13.01 and a high of $16.76.
Apr 2026: RAPT Stock Forecast
Potential ROI: 8.57%
In Apr 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $12.68. The price is predicted to fluctuate between a low of $10.56 and a high of $15.02.
May 2026: RAPT Stock Forecast
Potential ROI: 18.36%
In May 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $13.82. The price is predicted to fluctuate between a low of $11.69 and a high of $15.74.
Jun 2026: RAPT Stock Forecast
Potential ROI: -3.68%
In Jun 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $11.25. The price is predicted to fluctuate between a low of $9.55 and a high of $11.59.
Jul 2026: RAPT Stock Forecast
Potential ROI: 6.38%
In Jul 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $12.42. The price is predicted to fluctuate between a low of $11.55 and a high of $12.56.
Aug 2026: RAPT Stock Forecast
Potential ROI: 16.33%
In Aug 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $13.59. The price is predicted to fluctuate between a low of $12.03 and a high of $16.04.
Sep 2026: RAPT Stock Forecast
Potential ROI: -10.75%
In Sep 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $10.42. The price is predicted to fluctuate between a low of $9.36 and a high of $11.26.
Oct 2026: RAPT Stock Forecast
Potential ROI: 20.75%
In Oct 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $14.10. The price is predicted to fluctuate between a low of $12.03 and a high of $14.66.
Nov 2026: RAPT Stock Forecast
Potential ROI: -8.45%
In Nov 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $10.69. The price is predicted to fluctuate between a low of $8.14 and a high of $13.43.
Dec 2026: RAPT Stock Forecast
Potential ROI: -10.75%
In Dec 2026, RAPT Therapeutics Inc's value is forecasted to reach an average price of $10.42. The price is predicted to fluctuate between a low of $10.37 and a high of $11.65.
RAPT Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to RAPT Therapeutics Inc(RAPT), our algorithm predicts RAPT's 1-month price at $10.58, with an 0.82%upwardshift. Using a similarity score up to 97.89%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for RAPT Therapeutics Inc (RAPT.O) stock, as of Sunday, August 3, 2025 , forecasts a 0.82% change over the next month, based on its high correlation with UHAL.N stock patterns. The similarity between their price movements over the analyzed periods is 97.89%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
Based on RAPT's historical stock price data across all years, the probability of a positive return in August is50.00%, suggesting it maybe an ideal month to invest in RAPT. In contrast,Decemberoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying RAPT Therapeutics Inc (RAPT.O) stock in December has the highest probability of a positive return (100.00%), while February has the lowest probability (0.00%).
Performance Seasonality
The chart shows RAPT Therapeutics Inc. (RAPT)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy RAPT Therapeutics Inc (RAPT.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RAPT has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying RAPT Therapeutics Inc (RAPT.O) stock in a year?
The radar chart shows that buying RAPT Therapeutics Inc (RAPT.O) stock in December has the highest probability of a positive return (100.00%), while February has the lowest probability (0.00%).
How has RAPT Therapeutics Inc. (RAPT)'s stock price performed over the past three years?
RAPT's stock price rose by 33.53% in 2023,decreased by -93.50% in 2024, and went down by 23.39%in 2025.
Bearish technical signals of RAPT include: MOM_10 < 0, close < fibonacci_S1, 5-day SMA crosses below 20-day SMA.
Is RAPT a buy based on overall technical signals summary?
RAPT has 5 buy signals and 3 sell signals now. Overall the technical rating for RAPT is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of RAPT.
What is the trend of RAPT Therapeutics Inc (RAPT)'s moving average?
RAPT Therapeutics Inc's overall moving average trend leans more bearish as of August 07 2025, with 3 negative signals and 1 positive signal.
What is price prediction for RAPT stock next month?
The price prediction chart for RAPT Therapeutics Inc (RAPT.O) stock, as of August 03 2025, forecasts a 0.82% change over the next month, based on its high correlation with UHAL stock patterns. The similarity between their price movements over the analyzed periods is 97.89%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for RAPT Stock?
### **Price Prediction for RAPT Stock in 2025**
Based on the provided data and analysis, here is the price prediction for RAPT stock in 2025:
1. **Bullish Scenario**: RAPT stock could reach **$6.00** by the end of 2025, driven by positive catalysts such as the Phase 2b trial results for RPT904 and increased institutional interest following the HC Wainwright upgrade to Strong Buy with a $6 price target (599% upside).
2. **Moderate Scenario**: The stock may stabilize around **$2.00**, reflecting a more cautious outlook due to the Hold rating from UBS and the current market volatility.
### **Reasons for the Prediction**
- **Analyst Upgrades**: HC Wainwright upgraded RAPT to Strong Buy with a $6 price target, indicating strong confidence in the stock's potential.
- **Technical Indicators**: The stock shows bullish signs with an RSI of 63.84 and Stochastic Oscillator %K of 81.91, suggesting upward momentum.
- **Catalysts**: The upcoming Phase 2b trial for RPT904 and potential regulatory approvals could drive significant upside.
- **Valuation**: Despite negative earnings, the forward P/E ratio of -3.11 and cash on hand from recent financing activities provide room for growth.
###
What is price prediction 2030 for RAPT Stock?
### **Price Prediction for RAPT Stock by 2030**
Based on current trends and analyst upgrades, RAPT Therapeutics (RAPT) is expected to reach **$8.00 by 2030**.
- **Reason**: The stock has been upgraded to a "Buy" rating by HC Wainwright with a price target of $10, indicating strong confidence in its growth prospects due to its licensing deal with Jemincare and its focus on developing novel therapies for inflammatory diseases.
- **Current Price**: $1.19 (as of 2025-06-10).
- **Analyst Sentiment**: Moderate Buy with an average target of $8.00.
- **Technical Analysis**: The stock shows bullish signals with a MACD crossover and Stochastic Oscillator indicating an uptrend.
-